NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight

Go back to NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
(NASDAQ: ELAB) Delayed: 4.42 -0.36 (7.53%)
Previous Close $4.78    52 Week High
Open $4.68    52 Week Low
Day High $4.74    P/E N/A 
Day Low $4.35    EPS
Volume 21,904       

(NASDAQ: ELAB) Delayed: 4.42 -0.36 (7.53%)
Previous Close $4.78    52 Week High
Open $4.68    52 Week Low
Day High $4.74    P/E N/A 
Day Low $4.35    EPS
Volume 21,904